Logo-apb
Review Article

1. Medicinal Plants with Potential Inhibitory Bioactive Compounds against Coronaviruses
Olutayo Ademola Adeleye* ORCID, Oluyemisi Adebowale Bamiro, Lateef Gbenga Bakre ORCID, Florence Olubola Odeleye ORCID, Modupe Nofisat Adebowale, Olufemi Lionel Okunye, Mariam Adeola Sodeinde, Adannaya Charity Adebona, Farid Menaa* ORCID
Adv Pharm Bull. 2022;12(1): 7-16. doi: 10.34172/apb.2022.003
PMCID: PMC9012928     PMID: 35517886     Scopus ID: 85127137628    
Article
PDF
Full Text
XML
Cited By:
1
3
6
Review Article

2. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies
Sherin Joseph ORCID, Anila Kutty Narayanan* ORCID
Adv Pharm Bull. 2022;12(1): 34-44. doi: 10.34172/apb.2022.005
PMCID: PMC9012918     PMID: 35517888     Scopus ID: 85127157166    
Article
PDF
Full Text
XML
Cited By:
2
2
1
Editorial

3. Renin Angiotensin System and Covid-19 Infection
Francesco Ferrara* ORCID, Antonio Vitiello
Adv Pharm Bull. 2022;12(1): 1-4. doi: 10.34172/apb.2022.001
PMCID: PMC9012934     PMID: 35517880     Scopus ID: 85127162469    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Editorial

4. Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic
Francesco Ferrara* ORCID, Priscilla Santilli, Vilma D'Aiuto, Antonio Vitiello
Adv Pharm Bull. 2021;11(3): 393-394. doi: 10.34172/apb.2021.045
PMCID: PMC8421614     PMID: 34513612     Scopus ID: 85108918350    
Article
PDF
Full Text
XML
Cited By:
0
1
1

Editorial

5. Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach
Sara Razi ORCID, Zahra Molavi, Seyed Amir Mirmotalebisohi, Zahra Niknam, Marzieh Sameni, Vahid Niazi, Amirjafar Adibi, Mohsen Yazdani, Mohammad Mehdi Ranjbar, Hakimeh Zali* ORCID
Adv Pharm Bull. 2022;12(2): 206-216. doi: 10.34172/apb.2022.023
PMCID: PMC9106958     PMID: 35620342     Scopus ID: 85122964899    
Article
PDF
Full Text
XML
Cited By:
1
5
3

Review Article

6. Recent Update of COVID-19 Vaccines
Sameer A. Jadaan* ORCID, Abdul Waheed Khan ORCID
Adv Pharm Bull. 2022;12(2): 219-236. doi: 10.34172/apb.2022.045
PMCID: PMC9106961     PMID: 35620327     Scopus ID: 85128147762    
Article
PDF
Full Text
XML
Cited By:
1
2
0

Mini Review

7. Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2

Heba Salah Abbas* ORCID, Mona Mohame Abd-elhakeem, Rania Mostafa Abd El Galil, Omar Ahmed Reyad, Heba Ahmed Mohamed, Salma Emad Saber Ismail, Manal Ahmed Nabil
Adv Pharm Bull. 2023;13(1): 79-87. doi: 10.34172/apb.2023.006
PMCID: PMC9871270     PMID: 36721816    
Article
PDF
Full Text
XML
Cited By:
0
3
Research Article

8. Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat
Fatemeh Yaghoobizadeh* ORCID, Mohammad Roayaei Ardakani ORCID, Mohammad Mehdi Ranjbar ORCID, Mohammad Khosravi ORCID, Hamid Galehdari ORCID
Adv Pharm Bull. 2023;13(3): 563-572. doi: 10.34172/apb.2023.059
PMCID: PMC10460799     PMID: 37646054    
Article
PDF
Full Text
XML
Cited By:
0
0
Review Article

9. Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2
Musa Moetasam Zorab ORCID, Navid Mohammadjani, Morahem Ashengroph* ORCID, Mehran Alavi* ORCID
Adv Pharm Bull. 2023;13(3): 411-422. doi: 10.34172/apb.2023.065
PMCID: PMC10460808     PMID: 37646053    
Article
PDF
Full Text
XML
Cited By:
0
2
Review Article

10. Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications
Minu Treeza M ORCID, Sanu Augustine ORCID, Aparna Ann Mathew ORCID, S.K. Kanthlal* ORCID, Rajitha Panonummal* ORCID
Adv Pharm Bull. 2023;13(4): 678-687. doi: 10.34172/apb.2023.069
PMCID: PMC10676557     PMID: 38022818    
Article
PDF
XML
Cited By:
2

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by